Skip to main content

 Scientific publications

Imaging and clinical correlates with regorafenib in metastatic colorectal cancer.

Authors : Khan K, Cascinu S, Cunningham D, Kim SY, Oki E, Seery T, Shen L, Siena S, Tournigand C, Turhal NS, Hendlisz A
Year : 2020
Journal : Cancer Treat Rev
Volume : 86
Pages : 102020

Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.

Authors : Caparica R, Bruzzone M, Hachem GE, Ceppi M, Lambertini M, Glasberg J, de Azambuja E, Van Laethem JL, Hendlisz A
Year : 2020
Journal : Crit Rev Oncol Hematol
Volume : 149
Pages : 102940

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.

Authors : Franzoi MA, Vandeputte C, Eiger D, Caparica R, Brandão M, de Angelis C, Hendlisz A, Awada A, Piccart-Gebhart M, de Azambuja E
Year : 2020
Journal : Breast Cancer Res Treat
Volume : 181
Pages : 199-209

Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report.

Authors : Herchuelz M, Marin G, Derijckere ID, Vouche M, Delatte P, Donckier V, Liberale G, Hendlisz A, Artigas C, Bourgeois P, Flamen P
Year : 2020
Journal : Radiol Case Rep
Volume : 15
Pages : 548-551

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.

Authors : Craciun L, de Wind R, Demetter P, Willard-Gallo K, Lucidi V, Bohlok A, Michiels S, Bouazza F, Vouche M, Tancredi I, Verset G, Garaud S, Naveaux C, Gomez Galdon M, Hendlisz A, Derijckere ID, Flamen P, Larsimont D, Donckier V
Year : 2020
Journal : BMC Cancer
Volume : 20
Pages : 135

Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.

Authors : Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P
Year : 2020
Journal : Oncotarget
Volume : 11
Pages : 589-599

Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.

Authors : Bregni G, Akin Telli T, Camera S, Deleporte A, Moretti L, Bali MA, Liberale G, Holbrechts S, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Treat Rev
Volume : 83
Pages : 101948

Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.

Authors : Bregni G, Akin Telli T, Camera S, Baratelli C, Shaza L, Deleporte A, Moretti L, Bali MA, Liberale G, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Treat Rev
Volume : 82
Pages : 101930

PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.

Authors : Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F
Year : 2020
Journal : Cancer Lett
Volume : 469
Pages : 142-150

Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer

Authors : Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P
Year : 2019
Journal : J Nucl Med
Volume : 60
Pages : 178-184

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients.

Authors : Caparica R, Lengelé A, Bekolo W, Hendlisz A
Year : 2019
Journal : Autops Case Rep
Volume : 9
Pages : e2019087

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Authors : Levillain H, Duran Derijckere I, Ameye L, Guiot T, Braat A, Meyer C, Vanderlinden B, Reynaert N, Hendlisz A, Lam M, Deroose CM, Ahmadzadehfar H, Flamen P
Year : 2019
Journal : Eur J Nucl Med Mol Imaging
Volume : 46
Pages : 2270-2279

Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies.

Authors : Springuel L, Lonez C, Alexandre B, van Cutsem E, Machiels JH, Van den Eynde M, Prenen H, Hendlisz A, Shaza L, Carrasco J, Canon JL, Opyrchal M, Odunsi K, Rottey S, Gilham DE, Flament A, Lehmann FF
Year : 2019
Journal : BioDrugs
Volume : 33
Pages : 515-537

Update on transarterial approaches to locoregional treatment in hepatocellular carcinoma.

Authors : Delhaye C, Hendlisz A, Vouche M
Year : 2019
Journal : Curr Opin Oncol
Volume : 31
Pages : 339-345

Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Authors : Woff E, Kehagias P, Vandeputte C, Ameye L, Guiot T, Paesmans M, Hendlisz A, Flamen P
Year : 2019
Journal : J Nucl Med
Volume : 60
Pages : 1366-1372

Differentiated-Type Intraepithelial Neoplasia-Like Lesion Associated with Squamous Cell Carcinoma of the Anus: A Case Report with Molecular Profile.

Authors : Koopmansch C, Maris C, Demetter P, Van de Stadt J, Hendlisz A, DHaene N, Noël JC
Year : 2019
Journal : Case Rep Pathol
Volume : 2019
Pages : 2301640

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.

Authors : Charette N, Vandeputte C, Ameye L, Bogaert CV, Krygier J, Guiot T, Deleporte A, Delaunoit T, Geboes K, Van Laethem JL, Peeters M, Demolin G, Holbrechts S, Flamen P, Paesmans M, Hendlisz A
Year : 2019
Journal : BMC Cancer
Volume : 19
Pages : 134

The metabolic clinical risk score as a new prognostic model for surgical decision-making in patients with colorectal liver metastases.

Authors : Duran Derijckere I, Levillain H, Bohlok A, Mathey C, Nezri J, Muteganya R, Trotta N, Lucidi V, Bouazza F, Germanova D, Van Simaeys G, Goldman S, Hendlisz A, Flamen P, Donckier V
Year : 2019
Journal : J Surg Oncol

The close interrelation between colorectal cancer, infection and microbiota.

Authors : Massaut E, Hendlisz A, Klastersky J
Year : 2019
Journal : Curr Opin Oncol
Volume : 31
Pages : 362-367

Editorial: Adjuvant chemotherapy for rectal cancer: playing the devil's advocate.

Authors : Sclafani F, Hendlisz A
Year : 2019
Journal : Curr Opin Oncol
Volume : 31
Pages : 336-338